Cholesterol-depleting statin drugs protect postmitotically differentiated human neurons against ethanol- and human immunodeficiency virus type 1-induced oxidative stress in vitro

Journal of Virology

Volumn 81, Issue 3, 2007, Pages 1492-1501

  Acheampong, Edward ^a   Parveen, Zahida ^a   Mengistu, Aschalew ^a   Ngoubilly, Noel ^a   Wigdahl, Brian ^b   Lossinsky, Albert S ^c   Pomerantz, Roger J ^d   Mukhtar, Muhammad ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c HUNTINGTON MEDICAL RESEARCH INSTITUTES   (United States)

^d Tibotec Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 ISOPROSTAGLANDIN F2 ALPHA; ALCOHOL; ATORVASTATIN; CHOLESTEROL; HEAT SHOCK PROTEIN 70; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; NITRIC OXIDE SYNTHASE; SIMVASTATIN;

ALCOHOLISM; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IN VITRO STUDY; MITOSIS; MONOCYTE; NEUROPATHOLOGY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PLEIOTROPY; PRIORITY JOURNAL; SUPERNATANT; T LYMPHOCYTE;

CENTRAL NERVOUS SYSTEM DEPRESSANTS; CHOLESTEROL; ETHANOL; HIV-1; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; NEURONS; OXIDATIVE STRESS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33846527853     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01843-06     Document Type: Article

References (99)

1. Acheampong, E., M. Mukhtar, Z. Parveen, N. Ngoubilly, N. Ahmad, C. Patel, and R. J. Pomerantz. 2002. Ethanol strongly potentiates apoptosis induced by HIV-1 proteins in primary human brain microvascular endothelial cells. Virology 304:222-234.
2. Agnew, L. L., M. Kelly, J. Howard, S. Jeganathan, M. Batterham, R. A. Ffrench, J. Gold, and K. Watson. 2003. Altered lymphocyte heat shock protein 70 expression in patients with HIV disease. AIDS 17:1985-1988.
3. Akaike, T. 2001. Role of free radicals in viral pathogenesis and mutation. Rev. Med. Virol. 11:87-101.
4. Ancuta, P., A. Moses, and D. Gabuzda. 2004. Transendothelial migration of CD16+ monocytes in response to fractalkine under constitutive and inflammatory conditions. Immunobiology 209:11-20.
5. Apel, K., and H. Hirt. 2004. Reactive oxygen species: metabolism, oxidative stress, and signal transduction. Annu. Rev. Plant Biol. 55:373-399.
6. Asea, A., S. K. Kraeft, E. A. Kurt-Jones, M. A. Stevenson, L. B. Chen, R. W. Finberg, G. C. Koo, and S. K. Calderwood. 2000. HSP70 stimulates cytokine production through a CD14-dependent pathway, demonstrating its dual role as a chaperone and cytokine. Nat. Med. 6:435-442.
7. Bagasra, O., S. E. Bachman, L. Jew, R. Tawadros, J. Cater, G. Boden, I. Ryan, and R. J. Pomerantz. 1996. Increased human immunodeficiency virus type 1 replication in human peripheral blood mononuclear cells induced by ethanol: potential immunopathogenic mechanisms. J. Infect. Dis. 173:550-558.
8. Bagasra, O., A. Howeedy, R. Dorio, and A. Kajdacsy-Balla. 1987. Functional analysis of T-cell subsets in chronic experimental alcoholism. Immunology 61:63-69.
9. Bagby, G. J., D. A. Stoltz, P. Zhang, J. K. Kolls, J. Brown, R. P. Bohm, Jr., R. Rockar, J. Purcell, M. Murphey-Corb, and S. Nelson. 2003. The effect of chronic binge ethanol consumption on the primary stage of SIV infection in rhesus macaques. Alcohol. Clin. Exp. Res. 27:495-502.
10. Ballabh, P., A. Braun, and M. Nedergaard. 2004. The blood-brain barrier: an overview: structure, regulation, and clinical implications. Neurobiol. Dis. 16:1-13.
11. Barnham, K. J., C. L. Masters, and A. I. Bush. 2004. Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov. 3:205-214.
12. Beere, H. M. 2004. "The stress of dying": the role of heat shock proteins in the regulation of apoptosis. J. Cell Sci. 117:2641-2651.
13. Bolanos, J. P., P. Garcia-Nogales, and A. Almeida. 2004. Provoking neuroprotection by peroxynitrite. Curr. Pharm. Des. 10:867-877.
14. Boven, L. A., L. Gomes, C. Hery, F. Gray, J. Verhoef, P. Portegies, M. Tardieu, and H. S. Nottet. 1999. Increased peroxynitrite activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection. J. Immunol. 162:4319-4327.
15. Brenner, B. G., and Z. Wainberg. 2001. Heat shock proteins: novel therapeutic tools for HIV-infection? Expert Opin. Biol. Ther. 1:67-77.
16. Brew, B. J., N. Dunbar, L. Pemberton, and J. Kaldor. 1996. Predictive markers of AIDS dementia complex: CD4 cell count and cerebrospinal fluid concentrations of beta 2-microglobulin and neopterin. J. Infect. Dis. 174:294-298.
17. Brew, B. J., M. Rosenblum, and R. W. Price. 1988. AIDS dementia complex and primary HIV brain infection. J. Neuroimmunol. 20:133-140.
18. Bukrinsky, M. I., H. S. Nottet, H. Schmidtmayerova, L. Dubrovsky, C. R. Flanagan, M. E. Mullins, S. A. Lipton, and H. E. Gendelman. 1995. Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease. J. Exp. Med. 181:735-745.
19. Chen, W., Z. Tang, P. Fortina, P. Patel, S. Addya, S. Surrey, E. A. Acheampong, M. Mukhtar, and R. J. Pomerantz. 2005. Ethanol potentiates HIV-1 gp120-induced apoptosis in human neurons via both the death receptor and NMDA receptor pathways. Virology 334:59-73.
20. Cinque, P., L. Vago, D. Ceresa, F. Mainini, M. R. Terreni, A. Vagani, W. Torri, S. Bossolasco, and A. Lazzarin. 1998. Cerebrospinal fluid HIV-1 RNA levels: correlation with HIV encephalitis. AIDS 12:389-394.
21. del Real, G., S. Jimenez-Baranda, E. Mira, R. A. Lacalle, P. Lucas, C. Gomez-Mouton, M. Alegret, J. M. Pena, M. Rodriguez-Zapata, M. Alvarez-Mon, A. C. Martinez, and S. Manes. 2004. Statins inhibit HIV-1 infection by down-regulating Rho activity. J. Exp. Med. 200:541-547.
22. Dong, Q., S. Kelkar, Y. Xiao, S. Joshi-Barve, C. J. McClain, and S. S. Barve. 2000. Ethanol enhances TNF-α-inducible NFκB activation and HIV-1-LTR transcription in CD4+ Jurkat T lymphocytes. J. Lab. Clin. Med. 136:333-343.
23. Dreyer, E. B., D. Zurakowski, M. Gorla, C. K. Vorwerk, and S. A. Lipton. 1999. The contribution of various NOS gene products to HIV-1 coat protein (gp120)-mediated retinal ganglion cell injury. Investig. Ophthalmol. Vis. Sci. 40:983-989.
24. Farzaneh, P., A. Allameh, S. Pratt, N. Moore, L. Travis, E. Gottschalg, C. Kind, and J. Fry. 2005. Increased heat shock protein 70 expression following toxicant-mediated cytotoxicity: a ubiquitous marker of toxicant exposure? Altern. Lab. Anim. 33:105-110.
25. Fein, G., D. J. Fletcher, and V. Di Sclafani. 1998. Effect of chronic alcohol abuse on the CNS morbidity of HIV disease. Alcohol. Clin. Exp. Res. 22:196S-200S.
26. Fiala, M., A. J. Eshleman, J. Cashman, J. Lin, A. S. Lossinsky, V. Suarez, W. Yang, J. Zhang, W. Popik, E. Singer, F. Chiappelli, E. Carro, M. Weinand, M. Witte, and J. Arthos. 2005. Cocaine increases human immunodeficiency virus type 1 neuroinvasion through remodeling brain microvascular endothelial cells. J. Neurovirol. 11:281-291.
27. Floyd, R. A., K. Hensley, F. Jaffery, L. Maidt, K. Robinson, Q. Pye, and C. Stewart. 1999. Increased oxidative stress brought on by pro-inflammatory cytokines in neurodegenerative processes and the protective role of nitrone-based free radical traps. Life Sci. 65:1893-1899.
28. Giguère, J.-F., and M. J. Tremblay. 2004. Statin compounds reduce human immunodeficiency virus type 1 replication by preventing the interaction between virion-associated host intercellular adhesion molecule 1 and its natural cell surface ligand LFA-1. J. Virol. 78:12062-12065.
29. Goody, R. J., C. C. Hoyt, and K. L. Tyler. 2005. Reovirus infection of the CNS enhances iNOS expression in areas of virus-induced injury. Exp. Neurol. 195:379-390.
30. Green, J. E., R. V. Saveanu, and R. A. Bornstein. 2004. The effect of previous alcohol abuse on cognitive function in HIV infection. Am. J. Psychiatry 161:249-254.
31. Greenspan, H. C., and O. I. Aruoma. 1994. Oxidative stress and apoptosis in HIV infection: a role for plant-derived metabolites with synergistic antioxidant activity. Immunol. Today 15:209-213.
32. Gu, Z., M. Kaul, B. Yan, S. J. Kridel, J. Cui, A. Strongin, J. W. Smith, R. C. Liddington, and S. A. Lipton. 2002. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science 297:1186-1190.
33. Hartman, T. J., D. J. Baer, L. B. Graham, W. L. Stone, E. W. Gunter, C. E. Parker, P. S. Albert, J. F. Dorgan, B. A. Clevidence, W. S. Campbell, K. B. Tomer, J. T. Judd, and P. R. Taylor. 2005. Moderate alcohol consumption and levels of antioxidant vitamins and isoprostanes in postmenopausal women. Eur. J. Clin. Nutr. 59:161-168.
34. Hingson, R., T. Heeren, and M. Winter. 2000. Effects of recent 0.08% legal blood alcohol limits on fatal crash involvement. Inj. Prev. 6:109-114.
35. Hingson, R. W., T. Heeren, A. Jamanka, and J. Howland. 2000. Age of drinking onset and unintentional injury involvement after drinking. JAMA 284:1527-1533.
36. Iordanskiy, S., Y. Zhao, P. DiMarzio, I. Agostini, L. Dubrovsky, and M. Bukrinsky. 2004. Heat-shock protein 70 exerts opposing effects on Vpr-dependent and Vpr-independent HIV-1 replication in macrophages. Blood 104:1867-1872.
37. Iordanskiy, S., Y. Zhao, L. Dubrovsky, T. Iordanskaya, M. Chen, D. Liang, and M. Bukrinsky. 2004. Heat shock protein 70 protects cells from cell cycle arrest and apoptosis induced by human immunodeficiency virus type 1 viral protein R. J. Virol. 78:9697-9704.
38. Jerrells, T. R., C. A. Marietta, G. Bone, F. F. Weight, and M. J. Eckardt. 1988. Ethanol-associated immunosuppression. Adv. Biochem. Psychopharmacol. 44:173-185.
39. Kaul, M., J. Zheng, S. Okamoto, H. E. Gendelman, and S. A. Lipton. 2005. HIV-1 infection and AIDS: consequences for the central nervous system. Cell Death Differ. 12(Suppl. 1):878-892.
40. Koh, K. K., J. Y. Ahn, D. K. Jin, S. H. Ran, H. S. Kim, I. S. Choi, T. H. Ahn, E. K. Shin, and E. M. Jeong. 2004. Comparative effects of statin and fibrate on nitric oxide bioactivity and matrix metalloproteinase in hyperlipidemia. Int. J. Cardiol. 97:239-244.
41. Kolson, D. L. 2002. Neuropathogenesis of central nervous system HIV-1 infection. Clin. Lab. Med. 22:703-717.
42. Kolson, D. L., E. Lavi, and F. Gonzalez-Scarano. 1998. The effects of human immunodeficiency virus in the central nervous system. Adv. Virus Res. 50:1-47.
43. Koppal, T., J. Drake, S. Yatin, B. Jordan, S. Varadarajan, L. Bettenhausen, and D. A. Butterrield. 1999. Peroxynitrite-induced alterations in synaptosomal membrane proteins: insight into oxidative stress in Alzheimer's disease. J. Neurochem. 72:310-317.
44. Lawrence, D. M., L. C. Durham, L. Schwartz, P. Seth, D. Marie, and E. O. Major. 2004. Human immunodeficiency virus type 1 infection of human brain-derived progenitor cells. J. Virol. 78:7319-7328.
45. Lipton, S. A., and H. E. Gendelman. 1995. Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome. N. Engl. J. Med. 332:934-940.
46. Luan, Z., A. J. Chase, and A. C. Newby. 2003. Statins inhibit secretion of metalloproteinases-1, -2, -3, and -9 from vascular smooth muscle cells and macrophages. Arterioscler. Thromb. Vasc. Biol. 23:769-775.
47. Markesbery, W. R. 1997. Neuropathological criteria for the diagnosis of Alzheimer's disease. Neurobiol. Aging 18:S13-S19.
48. Mengistu, A., E. Acheampong, G. Nunnari, E. Argyris, M. Kalayeh, K. J. Williams, R. J. Pomerantz, and M. Mukhtar. 2004. Effects of statins on the transmigration of monocytes and T cells across the blood brain barrier, abstr. 481. 11th Conf. Retrovir. Opportunistic Infect., San Francisco, CA, 8 to 11 February 2004.
49. Meyerhoff, D. J., S. MacKay, D. Sappey-Marinier, R. Deicken, G. Calabrese, W. P. Dillon, M. W. Weiner, and G. Fein. 1995. Effects of chronic alcohol abuse and HIV infection on brain phosphorus metabolites. Alcohol. Clin. Exp. Res. 19:685-692.
50. Migita, K., Y. Maeda, S. Abiru, A. Komori, T. Yokoyama, Y. Takii, M. Nakamura, H. Yatsuhashi, K. Eguchi, and H. Ishibashi. 2005. Peroxynitrite-mediated matrix metalloproteinase-2 activation in human hepatic stellate cells. FEBS Lett. 579:3119-3125.
51. Miguez, M. J., G. Shor-Posner, G. Morales, A. Rodriguez, and X. Burbano. 2003. HIV treatment in drug abusers: impact of alcohol use. Addict. Biol. 8:33-37.
52. Mollace, V., H. S. Nottet, P. Clayette, M. C. Turco, C. Muscoli, D. Salvemini, and C. F. Perno. 2001. Oxidative stress and neuroAIDS: triggers, modulators and novel antioxidants. Trends Neurosci. 24:411-416.
53. Morrow, J. D., B. Frei, A. W. Longmire, J. M. Gaziano, S. M. Lynch, Y. Shyr, W. E. Strauss, J. A. Gates, and L. J. Roberts II. 1995. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage. N. Engl. J. Med. 332:1198-1203.
54. Morrow, J. D., T. M. Harris, and L. J. Roberts II. 1990. Noncyclooxygenase oxidative formation of a series of novel prostaglandins: analytical ramifications for measurement of eicosanoids. Anal. Biochem. 184:1-10.
55. Morrow, J. D., T. A. Minton, K. F. Badr, and L. J. Roberts II. 1994. Evidence that the F2-isoprostane, 8-epi-prostaglandin F2 alpha, is formed in vivo. Biochim. Biophys. Acta 1210:244-248.
56. Morrow J. D., and L. J. Roberts II. 1996. The isoprostanes. Current knowledge and directions for future research. Biochem. Pharmacol. 51:1-9.
57. Moses, A. V., and J. A. Nelson. 1994. HIV infection of human brain capillary endothelial cells-implications for AIDS dementia. Adv. Neuroimmunol. 4:239-247.
58. Moulignier, A., A. Moulonguet, G. Pialoux, and W. Rozenbaum. 2001. Reversible ALS-like disorder in HIV infection. Neurology 57:995-1001.
59. Mukhtar, M., E. Acheampong, Z. Parveen, and R. J. Pomerantz. 2005. T-cells and excitotoxicity: HIV-1 and other neurodegenerative disorders. Neuromol. Med. 7:265-273.
60. Mukhtar, M., S. Barley, P. Chen, M. BouHamdan, C. Patel, E. Acheampong, and R. J. Pomerantz. 2002. Primary isolated human brain microvascular endothelial cells express diverse HIV/SIV-associated chemokine coreceptors and DC-SIGN and L-SIGN. Virology 297:78-88.
61. Mukhtar, M., and R. J. Pomerantz. 2000. Development of an in vitro blood-brain barrier model to study molecular neuropathogenesis and neurovirologic disorders induced by human immunodeficiency virus type 1 infection. J. Hum. Virol. 3:324-334.
62. Nakahara, T., M. Hirano, H. Uchimura, S. Shirali, C. R. Martin, A. B. Bonner, and V. R. Preedy. 2002. Chronic alcohol feeding and its influence on c-Fos and heat shock protein-70 gene expression in different brain regions of male and female rats. Metabolism 51:1562-1568.
63. Neurauter, G., B. Wirleitner, A. Laich, H. Schennach, G. Weiss, and D. Fuchs. 2003. Atorvastatin suppresses interferon-gamma-induced neopterin formation and tryptophan degradation in human peripheral blood mononuclear cells and in monocytic cell lines. Clin. Exp. Immunol. 131:264-267.
64. Neuwelt, E. A. 2004. Mechanisms of disease: the blood-brain barrier. Neurosurgery 54:131-142.
65. Noseworthy, M. D., and T. M. Bray. 1998. Effect of oxidative stress on brain damage detected by MRI and in vivo 31P-NMR. Free Radic. Biol. Med. 24:942-951.
66. Pandey, S. C., A. Roy, and N. Mittal. 2001. Effects of chronic ethanol intake and its withdrawal on the expression and phosphorylation of the creb gene transcription factor in rat cortex. J. Pharmacol. Exp. Ther. 296:857-868.
67. Petito, C. K., B. Adkins, M. McCarthy, B. Roberts, and I. Khamis. 2003. CD4+ and CD8+ cells accumulate in the brains of acquired immunodeficiency syndrome patients with human immunodeficiency virus encephalitis. J. Neurovirol. 9:36-44.
68. Petito, C. K., J. E. Torres-Munoz, F. Zielger, and M. McCarthy. 2006. Brain CD8+ and cytotoxic T lymphocytes are associated with, and may be specific for, human immunodeficiency virus type 1 encephalitis in patients with acquired immunodeficiency syndrome. J. Neurovirol. 12:272-283.
69. Phillips, P. G., and L. M. Birnby. 2004. Nitric oxide modulates caveolin-1 and matrix metalloproteinase-9 expression and distribution at the endothelial cell/tumor cell interface. Am. J. Physiol. Lung Cell. Mol. Physiol. 286: L1055-L1065.
70. Pocernich, C. B., R. Sultana, H. Mohmmad-Abdul, A. Nath, and D. A. ButterHeld. 2005. HIV-dementia, Tat-induced oxidative stress, and antioxidant therapeutic considerations. Brain Res. Brain Res. Rev. 50:14-26.
71. Pol, S., P. Artru, V. Thepot, P. Berthelot, and B. Nalpas. 1996. Improvement of the CD4 cell count after alcohol withdrawal in HIV-positive alcoholic patients. AIDS 10:1293-1294.
72. Prakash, O., B. H. Joshi, P. Zhang, T. Y. Aw, S. Teng, M. Ali, J. E. Shellito, and S. Nelson. 1998. Transgenic mouse model of, ethanol as a cofactor in HIV disease. Alcohol. Clin. Exp. Res. 22:2668-2685.
73. Prakash, O., V. E. Rodriguez, Z. Y. Tang, P, Zhou, R. Coleman, G. Dhillon, J. E. Shellito, and S. Nelson. 2001. Inhibition of hematopoietic progenitor cell proliferation by ethanol in human immunodeficiency virus type 1 tat-expressing transgenic mice. Alcohol. Clin. Exp. Res. 25:450-456.
74. Pratico, D., and G. A. FitzGerald. 1996. Generation of 8-epiprostaglandin F2alpha by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2. J. Biol. Chem. 271:8919-8924.
75. Pratico, D., J. A. Lawson, and G. A. Fitzgerald. 1995. Cyclooxygenase dependent formation of 8-iso-prostaglandin F2 alpha by human platelets. Adv. Prostaglandin Thromboxane Leukot. Res. 23:229-231.
76. Racek, J., V. Holecek, D. Sedlacek, and P. Panzner. 2001. [Free radicals in immunology and infectious diseases]. Epidemiol. Mikrobiol. Imunol. 50:87-91. (In Czech.)
77. Rajagopalan, S., X. P. Meng, S. Ramasamy, D. G. Harrison, and Z. S. Galis. 1996. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J. Clin. Investig. 98:2572-2579.
78. Resnick, L., J. R. Berger, P. Shapshak, and W. W. Tourtellotte. 1988. Early penetration of the blood-brain-barrier by HIV. Neurology 38:9-14.
79. Roberts, L. J. II, and J. D. Morrow. 1994. Isoprostanes. Novel markers of endogenous lipid peroxidation and potential mediators of oxidant injury. Ann. N. Y. Acad. Sci. 744:237-242.
80. Russo, A., M. Palumbo, C. Scifo, V. Cardile, M. L. Barcellona, and M. Renis. 2001. Ethanol-induced oxidative stress in rat astrocytes: role of HSP70. Cell Biol. Toxicol. 17:153-168.
81. Sacktor, N., N. Haughey, R. Cutler, A. Tamara, J. Turchan, C. Pardo, D. Vargas, and A. Nath. 2004. Novel markers of oxidative stress in actively progressive HIV dementia. J. Neuroimmunol. 157:176-184.
82. Scalia, R. 2005. Statins and the response to myocardial injury. Am. J. Cardiovasc. Drugs 5:163-170.
83. Shi, B., J. Raina, A. Lorenzo, J. Busciglio, and D. Gabuzda. 1998. Neuronal apoptosis induced by HIV-1 Tat protein and TNF-alpha: potentiation of neurotoxicity mediated by oxidative stress and implications for HIV-1 dementia. J. Neurovirol. 4:281-290.
84. Shor-Posner, G., R. Lecusay, G. Morales, A. Campa, and M. J. Miguez-Burbano. 2002. Neuroprotection in HIV-positive drug users: implications for antioxidant therapy. J. Acquir. Immune Defic. Syndr. 31(Suppl. 2):S84-S88.
85. Sipos, H., B. Torocsik, L. Tretter, and V. Adam-Vizi. 2005. Impaired regulation of pH homeostasis by oxidative stress in rat brain capillary endothelial cells. Cell. Mol. Neurobiol. 25:141-151.
86. Skaper, S. D., M. Floreani, M. Ceccon, L. Facci, and P. Giusti. 1999. Excitotoxicity, oxidative stress, and the neuroprotective potential of melatonin. Ann. N. Y. Acad. Sci. 890:107-118.
87. Spector, S. A., K. Hsia, D. Pratt, J. Lathey, J. A. McCutchan, J. E. Alcaraz, J. H. Atkinson, S. Gulevich, M. Wallace, and I. Grant. 1993. Virologic markers of human immunodeficiency virus type 1 in cerebrospinal fluid. The HIV Neurobehavioral Research Center Group. J. Infect. Dis. 168:68-74.
88. Stebbing, J., B. Gazzard, L. Kim, S. Portsmouth, A. Wildfire, I. Teo, M. Nelson, M. Bower, F. Gotch, S. Shaunak, P. Srivastava, and S. Patterson. 2003. The heat-shock protein receptor CD91 is up-regulated in monocytes of HIV-1-infected "true" long-term nonprogressors. Blood 101:4000-4004.
89. Stins, M. F., D. Pearce, H. Choi, F. Di Cello, C. A. Pardo, and K. S. Kim. 2004. CD4 and chemokine receptors on human brain microvascular endothelial cells, implications for human immunodeficiency virus type 1 pathogenesis. Endothelium 11:275-284.
90. Szabó, C. 2003. Multiple pathways of peroxynitrite cytotoxicity. Toxicol. Lett. 140-141:105-112.
91. Toborek, M., Y. W. Lee, G. Flora, H. Pu, I. E. Andras, E. Wylegala, B. Hennig, and A. Nath. 2005. Mechanisms of the blood-brain barrier disruption in HIV-1 infection. Cell. Mol. Neurobiol. 25:181-199.
92. Torres-Muñoz, J., P. Stockton, N. Tacoronte, B. Roberts, R. R. Maronpot, and C. K. Petite. 2001. Detection of HIV-1 gene sequences in hippocampal neurons isolated from postmortem AIDS brains by laser capture microdissection. J. Neuropathol. Exp. Neurol. 60:885-892.
93. Turchan, J., C. B. Pocernich, C. Gairola, A. Chauhan, G. Schifitto, D. A. Butterfield, S. Buch, O. Narayan, A. Sinai, J. Geiger, J. R. Berger, H. Elford, and A. Nath. 2003. Oxidative stress in HIV demented patients and protection ex vivo with novel antioxidants. Neurology 60:307-314.
94. Unno, K., H. Asakura, Y. Shibuya, M. Kaihou, H. Fukatsu, S. Okada, and N. Oku. 2002. Stress response caused by chronic alcohol intake in aged rat brain. Alcohol. Clin. Exp. Res. 26:1017-1023.
95. Watson, K. 1990. Microbial stress proteins. Adv. Microb. Physiol. 31:183-223.
96. Weitz-Schmidt, G., K. Welzenbach, V. Brinkmann, T. Kamata, J. Kallen, C. Bruns, S. Cottens, Y. Takada, and U. Hommel. 2001. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat. Med. 7:687-692.
97. Wu, D., and A. I. Cederbaum. 2003. Alcohol, oxidative stress, and free radical damage. Alcohol Res. Health 27:277-284.
98. Zhang, L., W. Yu, T. He, J. Yu, R. E. Caffrey, E. A. Dalmasso, S. Fu, T. Pham, J. Mei, J. J. Ho, W. Zhang, P. Lopez, and D. D. Ho. 2002. Contribution of human alpha-defensin 1,2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 298:995-1000.
99. Zhou, N., X. Fan, M. Mukhtar, J. Fang, C. A. Patel, G. C. DuBois, and R. J. Pomerantz. 2003. Cell-cell fusion and internalization of the CNS-based, HIV-1 co-receptor, APJ. Virology 307:22-36.